Drug Profile
House dust mite allergy immunotherapy sublingual - HAL Allergy
Alternative Names: SUBLIVAC FIX MiteLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator HAL Allergy
- Class Allergens; Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Allergic rhinitis; Allergic rhinoconjunctivitis
Most Recent Events
- 14 Jan 2015 HAL Allergy initiates enrolment in a phase II trial for Allergic rhinitis and Rhinoconjunctivitis in Germany (EudraCT2014-002047-18)